"Changes in Brain Activity with Antisense Oligonucleotide RG6042 Treatment in Early Manifest Huntington’s Disease (HD) (4003)." Neurology
94.15 Supplement
(2020):
4003.
Web. 26 Mar. 2023.
Advertisement
The most widely read and highly cited peer-reviewed neurology journal
